Literature DB >> 4823973

Latent carcinoma of the prostate--why the controversy?

R J Correa, R G Anderson, R P Gibbons, J T Mason.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4823973     DOI: 10.1016/s0022-5347(17)60036-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Authors:  S Battaglia; G Barbolini; A R Botticelli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

Review 2.  Immediate versus deferred treatment for early prostatic cancer.

Authors:  P H Smith; T G Armitage
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

3.  Comparative clinical features of stage A1 and stage A2 prostate cancers. Is the concept of stage A changing from the current status?

Authors:  K Kunimi; T Amano; S W Lee; H Fuse; T Uchibayashi; K Miyazaki; M Ohkawa
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

4.  Early (stage A) prostatic cancer. VI. A critical look at the follow-up.

Authors:  S Battaglia; G Barbolini; A R Botticelli; G Berri; E Nigrisoli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

5.  Latent carcinoma of the prostate in a 24-year-old man receiving cyclophosphamide and azathioprine.

Authors:  G B Elliott; D S Silverberg; J B Dossetor; C S Muir
Journal:  Can Med Assoc J       Date:  1977-03-19       Impact factor: 8.262

6.  Adenocarcinoma of the prostate in perspective.

Authors:  A W Bruce; D E Mahan
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

7.  Diagnosis, prognosis and management of incidentally found prostate cancer.

Authors:  P J Davidson
Journal:  Urol Res       Date:  1993-01

8.  E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma.

Authors:  T Otto; K Rembrink; M Goepel; M Meyer-Schwickerath; H Rübben
Journal:  Urol Res       Date:  1993

9.  Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.

Authors:  P N Brawn; E H Johnson; V O Speights; M Riggs; M Lind; N Bell
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.